LifeStance Health reports new anxiety medications are expected for 2026, featuring innovative treatments in clinical trials ...

Anxiety is part of being human, but suffering with it doesn’t have to be. Here are some research-backed goals to help reduce ...

Morning anxiety feels like it comes out of nowhere, but psychologists say it usually has a very clear source. Here are the ...

An analysis of major depressive disorder, covering diagnostic criteria, prevalence statistics across demographics, and ...

Smartphone-based cognitive-behavioral therapy outperforms psychoeducation for generalized anxiety disorder, with benefits ...

Analysts are intrested in these 5 stocks: ( ($AME) ), ( ($MNMD) ), ( ($ATAI) ), ( ($PRME) ) and ( ($KBH) ). Here is a breakdown of their recent ...

Williams, A. and Louis, L. (2026) Cumulative Link Modeling of Ordinal Outcomes in the National Health Interview Survey Data: Application to Depressive Symptom Severity. Journal of Data Analysis and ...

SSRIs are often the first choice for treating depression and various anxiety disorders. Medications for anxiety and depression work by boosting neurotransmitters like serotonin, norepinephrine, ...

Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point they rarely leave their home and are unable to work and build meaningful ...

NEW YORK--(BUSINESS WIRE)--Researchers from Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...

Researchers from Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health ...